Uncategorised - European Medical Journal

asthma

New Insights into Asthma: Pseudo Leukotrienes and Inflammation

The study found that urinary øLT levels were significantly elevated, four- to five-fold higher, in patients with severe asthma compared to healthy controls.

IDWeek 2025: C. diff Deaths Show Stark Demographic Gaps

A 25-year USA study finds C. diff deaths highest among White people, women, and city residents, though overall mortality has fallen since 2015.

Elderly woman using a nebulizer for respiratory treatment while holding hands with a healthcare provider

CHEST 2025: Nerandomilast Shows Promise in Slowing IPF Decline

In a Phase III trial, the addition of nerandomilast demonstrated a promising ability to slow disease progression in patients with idiopathic pulmonary fibrosis (IPF).

Processed Food Undermines Benefits of a Plant-Based Diet

Processed food level, not plant-based label, determines heart disease risk, according to new French longitudinal cohort research.

One in Three Europeans Cannot Identify Cystitis, Study Warns

A major European survey finds that one in three people cannot identify cystitis as a bladder infection and that half remain unaware women are most at risk.

ESMO Presidential Interview: Fabrice André

I went into cancer care and cancer research because, when I was a fellow, it was the medical specialty with the largest number of challenges…

Unmet Need in 1L HR+/HER2- Advanced Breast Cancer

Explore why outcomes often decline after first-line endocrine therapy in HR+/HER2- advanced breast cancer and how emerging treatments…

Real-World Insights on High-Dose Flu Vaccination

This infographic summarizes findings from FLUNITY-HD, the largest ever individually randomized influenza vaccine effectiveness trial…

New MRI Technique Detects Early Frontotemporal Dementia

A GENFI study reveals a new MRI method detects early frontotemporal dementia changes before symptoms or brain shrinkage.

The Obesity Puzzle in the Era of GLP-1s

In this series, host Saranya Ravindran speaks with Holly Wyatt about the evolving landscape of obesity treatment in the era of glucagon-like peptide-1 (GLP-1) medications.